Skip to main content

Month: February 2025

Meritage Homes Announces Pricing of $500 Million of 5.650% Senior Notes Due 2035

SCOTTSDALE, Ariz., Feb. 27, 2025 (GLOBE NEWSWIRE) — Meritage Homes Corporation (NYSE: MTH, “Meritage” or the “Company”) announced today that it has priced a registered underwritten public offering of $500 million aggregate principal amount of 5.650% Senior Notes due 2035 (the “senior notes”). The senior notes will pay interest semi-annually at a rate of 5.650% per year and will mature on March 15, 2035. The closing of the offering is expected to occur on March 6, 2025, subject to the satisfaction of customary closing conditions. Meritage intends to use the net proceeds of the offering for general corporate purposes. J.P. Morgan Securities LLC, BofA Securities, Inc., Goldman Sachs & Co. LLC, Mizuho Securities USA LLC, Fifth Third Securities, Inc., PNC Capital Markets LLC, Regions Securities LLC, Truist Securities, Inc. and...

Continue reading

Extendicare Announces 2024 Fourth Quarter and Full Year Results and Dividend Increase

MARKHAM, Ontario, Feb. 27, 2025 (GLOBE NEWSWIRE) — Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) today reported results for the three and twelve months ended December 31, 2024. Fourth Quarter 2024 HighlightsAdjusted EBITDA(1) excluding out-of-period items increased by $10.1 million or 43.5% to $33.4 million driven by improvements in all three business segments. Home health care average daily volume (“ADV”) increased to 30,993, an increase of 10.1% from Q4 2023. SGP third-party and joint venture serviced beds increased 7.4% from Q4 2023 to 146,300 beds, driven by continued organic growth. As previously announced, the Company entered into an agreement with Revera Inc. and certain of its affiliates (“Revera”) to acquire nine Class C LTC homes located in Ontario and Manitoba and a parcel of land for approximately $60.3...

Continue reading

Live Oak Acquisition Corp. V Announces the Pricing of $200,000,000 Initial Public Offering

New York, NY, Feb. 27, 2025 (GLOBE NEWSWIRE) — Live Oak Acquisition Corp. V (the “Company”) announced today the pricing of its initial public offering of 20,000,000 units. The units are expected to be listed on the Nasdaq Global Market (“Nasdaq”) and begin trading tomorrow, February 28, 2025 under the ticker symbol “LOKVU.” Each unit consists of one Class A ordinary share and one-half of one redeemable warrant.  Each whole warrant entitles the holder thereof to purchase one Class A ordinary share at a price of $11.50 per share, subject to adjustment. Only whole warrants are exercisable. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. The warrants will become exercisable 30 days after the completion of the Company’s initial business combination, and will expire five years after...

Continue reading

Supremex Announces Departure of Chief Financial Officer

MONTRÉAL, Feb. 27, 2025 (GLOBE NEWSWIRE) — Supremex Inc. (“Supremex” or the “Company”) (TSX: SXP), a leading North American manufacturer and marketer of envelopes and a growing provider of paper-based packaging solutions, today announces the departure of its Chief Financial Officer and Corporate Secretary, François Bolduc. Mr. Bolduc is leaving to pursue new professional challenges and will officially conclude his duties on March 20, 2025. “During his tenure, François led many important strategic and operational initiatives, while mobilizing a strong and capable team of professionals. We would like to thank François for his services to Supremex and we wish him the best of luck with all his future endeavors,” said Stewart Emerson, President & CEO of Supremex. Supremex has established a transition plan. Stewart Emerson will...

Continue reading

Lithium Ionic Files NI 43-101 Technical Report for the Baixa Grande Mineral Resource Estimate, Minas Gerais, Brazil, Marking a 32% Growth in Updated Mineral Resources

TORONTO, Feb. 27, 2025 (GLOBE NEWSWIRE) — Lithium Ionic Corp. (TSXV: LTH; OTCQX: LTHCF; FSE: H3N) (the “Company” or “Lithium Ionic”) reports that it has filed the independent NI 43-101 compliant technical report for its Baixa Grande Lithium Project (“Baixa Grande” or the “Project”) in Minas Gerais State, Brazil, related to the updated Mineral Resource Estimate (“MRE”) for the Project announced on January 14, 2025. The technical report, titled “Independent Technical Report on the Mineral Resource Estimate for the Baixa Grande Salinas Lithium Project, Minas Gerais, Brazil” was prepared by GE21 Consultoria Mineral Ltda. (“GE21”) in accordance with National Instrument 43-101 Standards of Disclosure for Mineral Projects (“NI 43-101”) and has an effective date of December 2, 2024. The report details the MRE comprising Measured and Indicated...

Continue reading

ECN Capital Reports US$0.02 in Adjusted Net Income per Common Share in Q4-2024

Solid Q4 2024 Results TORONTO, Feb. 27, 2025 (GLOBE NEWSWIRE) — ECN Capital Corp. (TSX: ECN) (“ECN Capital” or the “Company”) today reported financial results for the fourth quarter and the year ended December 31, 2024. For the three-month period ended December 31, 2024, ECN Capital reported Adjusted net income (loss) applicable to common shareholders of $4.4 million or $0.02 per share (basic) versus $13.1 million or $0.05 per share (basic) for the previous three-month period and ($13.5) million or ($.05) per share (basic) for the prior year comparable period. “Our Q4 results, while impacted by severe weather disruptions, further underline that 2024 marked the completion of our turnaround and we are well positioned and confident in our businesses going ahead,” said Steven Hudson, CEO of ECN Capital Corp. “Adjusted net income per...

Continue reading

Guardian Capital Group Limited (TSX: GCG; GCG.A) Announces 2024 Annual Operating Results

TORONTO, Feb. 27, 2025 (GLOBE NEWSWIRE) — All per share figures disclosed below are stated on a diluted basis.For the years ended December 31,       2024     2023  ($ in thousands, except per share amounts)                 Net revenue     $ 323,403   $ 241,182  Operating earnings       38,824     59,849  Net gains       77,444     57,787  Net earnings from continuing operations       101,598     102,162  Net earnings from discontinued operations       —     554,933  Net earnings       101,598     657,095                    EBITDA(1)     $ 70,874   $ 85,424  Adjusted cash flow from operations(1)       57,536     72,763                    Attributable to shareholders:        Net earnings from continuing operations     $ 100,099   $ 100,250  Net earnings       ...

Continue reading

Life360 Reports Record Q4 and FY 2024 Results

Monthly Active Users Reached Approximately 79.6 million Record Annual Global Net Additions to Paying Circles of 457 thousand – Reaching Nearly 2.3 millionTotal Quarterly Revenue Grew 33% Year-Over-Year to $115.5 million Annualized Monthly Revenue increased 34% Year-Over-Year to $367.6 millionAchieved Positive Net Income in Q4 and Record Positive Adjusted EBITDA of $45.5 million for the Year SAN FRANCISCO, Feb. 27, 2025 (GLOBE NEWSWIRE) — Life360, Inc. (“Life360” or the “Company”) (NASDAQ: LIF, ASX: 360), the San Francisco-based leader in family safety and connection, today announced unaudited financial results for the fourth quarter and audited financial results for the full year ended December 31, 2024. Building on the momentum of prior quarters, the Company achieved record-breaking results across key metrics, including...

Continue reading

Pacira BioSciences Acquires Remaining Equity Stake of GQ Bio

— Advances Pacira’s “5×30” path to becoming an innovative biopharmaceutical organization — — Adds novel, high-capacity, local-delivery platform for the development of genetic medicines with disease-modifying potential for prevalent musculoskeletal diseases with significant unmet needs — — Brings preclinical portfolio and research and development talent — — Provides expected near-term and long-term financial benefits with elimination of future milestone payments — PARSIPPANY, N.J., Feb. 27, 2025 (GLOBE NEWSWIRE) — Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients, today announced it has acquired the remaining 81 percent equity stake of GQ Bio Therapeutics GmbH for approximately...

Continue reading

RadNet Reports Fourth Quarter 2024 Results, Including Record Revenue and Adjusted EBITDA(1) and Releases 2025 Financial Guidance

Total Company Revenue increased 13.5% to a quarterly record of $477.1 million in the fourth quarter of 2024 from $420.4 million in the fourth quarter of 2023; Revenue from the Digital Health reportable segment (inclusive of intersegment revenue) increased 28.1% to $18.9 million in the fourth quarter of 2024 from $14.7 million in the fourth quarter of 2023 Total Company Adjusted EBITDA(1) was a quarterly record of $75.0 million in the fourth quarter of 2024 as compared with $65.8 million in the fourth quarter of 2023, an increase of 14.0%; Digital Health reportable segment Adjusted EBITDA(1) increased 61.6% to $4.5 million in the fourth quarter of 2024 from $2.8 million in the fourth quarter of 2023 Adjusting for unusual or one-time items impacting Net Income in the quarter, Adjusted Earnings Per Share(3) was $0.22 for the fourth quarter...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.